| (USD) | Sep 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -6.40M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SYRS returned -99.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -71.4% |
| 1 year | -99.5% |
| 5 years | -100.0% |
| 10 years | -100.0% |
| All-time high | $228.20 (Jul 2017) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SYRS would be worth today ›No. Syros Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Syros Pharmaceuticals, Inc. is part of the Healthcare sector.
Syros Pharmaceuticals, Inc. has a market cap of 2.68K USD, based on the latest quote.